014570 — Korean Drug Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual cashflow statement for Korean Drug Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	9,042	11,809	-4,917	2,995	6,512
Depreciation
Amortisation
Non-Cash Items	3,884	2,584	12,939	2,645	3,022
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5,590	-9,863	-11,770	-2,841	1,607
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	8,806	5,913	-1,999	4,869	13,110
Capital Expenditures	-1,159	-6,477	-5,934	-1,043	-475
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,095	1,076	18,211	-9,846	-10,057
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-8,254	-5,401	12,277	-10,889	-10,532
Financing Cash Flow Items	—	—	-2.9	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-2,789	-1,906	-2,008	-1,573	-1,790
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,227	-1,415	8,263	-7,586	782